QTc Prolongation: Possible Association with Risperidone and/or Haloperidol [1]

Psychosomatics

Volumn 44, Issue 6, 2003, Pages 521-

  Nandagopal, Jayasree J ^a   Craig, Jeffrey M ^a   Lippmann, Steven ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; OLANZAPINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; ZIPRASIDONE;

ADULT; AGE; CASE REPORT; DOSE RESPONSE; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART RATE; HUMAN; LETTER; LONG QT SYNDROME; MALE; METABOLISM; RISK FACTOR; SCHIZOPHRENIA; SEX DIFFERENCE; TACHYCARDIA;

EID: 0347568648     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.44.6.521     Document Type: Letter

References (6)

1. Brown K, Levy H, Brenner C, Leffler S, Hamburg EL: Overdose of risperidone. Ann Emerg Med 1993; 22:1908-1910
2. Lo Vecchio F, Hamilton RJ, Hoffman RJ: Risperidone overdose (letter). Am J Emerg Med 1996; 14:95-96
3. Package insert: Risperdal (risperidone). Titusville, NJ, Janssen, December 1994
4. Ravin DS, Levenson JW: Fatal cardiac event following initiation of risperidone therapy. Ann Pharmacother 1997; 31:867-870
5. Lawrence KR, Nasraway SA: Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature. Pharmacotherapy 1997; 17:531-537
6. Sharma ND, Rosman HS, Padhi ID, Tisdale JE: Torsades de pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998; 81:238-240